Uncomplicated Urinary Tract Infection Epidemiology Forecast 2025-2034

Uncomplicated urinary tract infection is a bladder infection that is highly prevalent in young, sexually active women. Urinary tract infections, including the uncomplicated type, are considered the most common outpatient infections, with nearly 50% to 60% of female adults estimated to develop such complications in their lifetime.

Uncomplicated Urinary Tract Infection Epidemiology Forecast Report Coverage

The “Uncomplicated Urinary Tract Infection Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of uncomplicated urinary tract infection. It projects the future incidence and prevalence rates of uncomplicated urinary tract infection across various populations. The study covers age and type as major determinants of the uncomplicated urinary tract infection-affected population. The report highlights patterns in the prevalence of uncomplicated urinary tract infection over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of uncomplicated urinary tract infection in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Uncomplicated Urinary Tract Infection: Disease Overview

Uncomplicated urinary tract infections (UTIs) refer to an infection of the urinary bladder (cystitis) that occurs in otherwise healthy individuals with anatomically and functionally normal urinary tracts. These infections are commonly observed in women due to their shorter urethra and proximity to the anus, which makes the entry of bacteria easier. Escherichia coli is the leading causative agent of uncomplicated urinary tract infections, with other bacteria including Klebsiella pneumoniae, Proteus mirabilis, Staphylococcus saprophyticus, and Enterococcus species.

Uncomplicated Urinary Tract Infection: Treatment Overview

Uncomplicated urinary tract infection antibiotics and supportive measures are predominantly used for the treatment of uncomplicated urinary tract infections. Since most of the uncomplicated UTIs are caused by Escherichia coli, they are often treated with Nitrofurantoin (Macrobid), Trimethoprim-Sulfamethoxazole (TMP-SMX, Bactrim), or Fosfomycin (Monurol). In cases of bacterial resistance, Fluoroquinolones such as Ciprofloxacin and Levofloxacin are prescribed to the patient. Beta-lactams are given to patients with allergies to first-line agents or in cases where other antibiotics fail to show adequate response.

Epidemiology

The uncomplicated urinary tract infection epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for uncomplicated urinary tract infections by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for uncomplicated urinary tract infection and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• Urinary tract infections, including complicated and uncomplicated infections, are estimated to have a lifetime incidence of 50% to 60% in adult women and are considered the most common outpatient infections.
• The symptoms of uncomplicated urinary tract infections usually last for 2 to 4 days. However, nearly 30% of individuals experience a recurrence within 6 months of the infection.
• Urinary tract infections are reported to occur almost 4 times more frequently in women than men, with around 10% of women developing this complication annually.
• Studies show that UTIs are common between the ages of 16 to 35 years. Further, the recurrence rate is also observed to be high, with approximately half of the patient pool experiencing a second infection within a year.

Country-wise Uncomplicated Urinary Tract Infection Epidemiology

The uncomplicated urinary tract infection epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of uncomplicated urinary tract infections varies significantly between countries due to differences in factors such as hygiene practices, healthcare infrastructure, antibiotic resistance patterns, and lifestyle behaviors, among others. In the United States, sexually active females experience approximately 0.5 episodes of cystitis, a common type of urinary tract infection, per person each year.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of uncomplicated urinary tract infection based on several factors.
• Uncomplicated Urinary Tract Infection Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of uncomplicated urinary tract infections are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of uncomplicated urinary tract infection epidemiology in the 8 major markets?
• What will be the total number of patients with uncomplicated urinary tract infections across the 8 major markets during the forecast period?
• What was the country-wise prevalence of uncomplicated urinary tract infection in the 8 major markets in the historical period?
• Which country will have the highest number of uncomplicated urinary tract infection patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of uncomplicated urinary tract infection during the forecast period of 2025-2034?
• What are the currently available treatments for uncomplicated urinary tract infections?
• What are the disease risks, signs, symptoms, and unmet needs of uncomplicated urinary tract infection?

This product will be delivered within 3-5 business days.